Resources

Note: Document title translations for resources written only in Japanese are provided by AMR Alliance Japan for reference purposes. These titles should not be considered official translations.

注意事項:一部の資料は日本語のみで公開されています。当該資料のタイトルはAMRアライアンス・ジャパンによる翻訳であり、定訳ではございません。

1. AMR Alliance Japan Resources

2. AMR Alliance Japan Member Resources

Shionogi & Co., Ltd.

The Japanese Society for Medical Mycology

Japanese Society of Pharmaceutical Health Care and Sciences

Japanese Society of Chemotherapy

Japanese Society for Infection Prevention and Control

The Japanese Association for Infectious Diseases

Japanese Society for Pediatric Infectious Diseases

Japan Pharmaceutical Manufacturers Association

AMR General/AMR Countermeasures Awareness
Research and Development Promotion
Recommendations to the G7/G20

Nippon Becton, Dickinson and Company, Ltd.

The Pharmaceutical Society of Japan

The Japanese Society for Clinical Microbiology

Three Academic Societies Joint Antimicrobial Susceptibility Surveillance Program Database

3. External Resources on AMR

YearTitleAuthorCountry/RegionTheme 
2020JANIS About PageJANISJapan2. Constructing domestic AMR surveillance and crisis management systems
2018JANIS Open ReportJANISJapan2. Constructing domestic AMR surveillance and crisis management systems
2018Automated detection of outbreaks of antimicrobial-resistant bacteria in JapanJournal of Hospital InfectionJapan2. Constructing domestic AMR surveillance and crisis management systems
2016National Action Plan on Antibacterial Resistance (AMR) 2016-2020The Government of JapanJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities/2. Constructing domestic AMR surveillance and crisis management systems/7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2017Nippon AMR One Health Report 2017The AMR One Health Surveillance CommitteeJapan2. Constructing domestic AMR surveillance and crisis management systems/7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019Three Academic Societies Joint Antimicrobial Susceptibility Surveillance ProgramThree Academic Societies Joint Antimicrobial Susceptibility Surveillance Program Japan2. Constructing domestic AMR surveillance and crisis management systems
2019Japan Antimicrobial Consumption Surveillance System (JACS)JACSJapan2. Constructing domestic AMR surveillance and crisis management systems
2020Japan Surveilliance for Infection Prevention and Healthcare Epidemiology (J-SIPHE)Japan Surveilliance for Infection Prevention and Healthcare Epidemiology (J-SIPHE)Japan2. Constructing domestic AMR surveillance and crisis management systems
2018Global Antimicrobial Resistance Surveillance (GLASS) Report 2016-2017World Health OrganizationGlobal2. Constructing domestic AMR surveillance and crisis management systems/7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020European Antimicrobial Resistance Surveillance Network (EARS-Net)European Center for Disease Prevention and ControlEurope2. Constructing domestic AMR surveillance and crisis management systems
2020Latin American Network for Antimicrobial Resistance Surveillance - ReLAVRAPan American Health OrganizationLatin America2. Constructing domestic AMR surveillance and crisis management systems
2019Central Asian and European Surveillance of Antimicrobial Resistance. Annual report 2019World Health Organization Regional Office for EuropeCentral Asia and Eastern Europe2. Constructing domestic AMR surveillance and crisis management systems
2019The National Antimicrobial Resistance Monitoring System (NARMS)Center for Disease Control and PreventionUnited States2. Constructing domestic AMR surveillance and crisis management systems
2017AMR Surveillance in low and middle-income settings - A roadmap for participation in the Global Antimicrobial Surveillance System (GLASS)Wellcome Open ReserchLow-middle income countries2. Constructing domestic AMR surveillance and crisis management systems
2020ICT & ASTCenter Hospital of the National Center for Global Health and MedicineJapan2. Constructing domestic AMR surveillance and crisis management systems/3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology/4. Supporting education on AMR for the public and medical practitioners
2015Rapid Diagnostic: Stopping Unnecessary Use of AntibioticsWellcome TrustGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020the Joint Programming Initiative on Antimicrobial ResistanceJoint Programming Initiative on Antimicrobial ResistanceEurope3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020Joint Programming Initiative on Antimicrobial Resistance: JapanJoint Programming Initiative on Antimicrobial ResistanceJapan3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020AMR Dx GlobalJoint Programming Initiative on Antimicrobial ResistanceEurope3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019AMR Diagnostic ChallengeNational Institutes of HealthUnited States3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratoriesBMC Health Services ResearchJapan3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2015Infection Prevention, Control and Surveillance: Limiting the Development and Spread of Drug ResistanceWellcome TrustGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017White Paper on Rapid Diagnostic Technlogies to Tackle AMRHealth First EuropeEurope3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018Innovation in AMR: patents trends for novel diagnosticsLongitude PrizeGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016Diagnostic stewardship:A guide to implementation in antimicrobial resistance surveillance sitesWorld Health OrganizationGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019Molecular methods for antimicrobial resistance (AMR) diagnostics to enhance the Global Antimicrobial Resistance Surveillance SystemWorld Health OrganizationGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016Emerging Technlogies for Clinical Microbiology Laboratory: Rapid Antimicrobial Susceptibility Testing UpdateKanto Chemical Co., Inc.Japan3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017Advances in Rapid Identification and Sucseptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship ProgramsInfectious Disease ReportGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019Advances in Diagnostic Testing that Impact Infection Prevention and Antimicrobial Stewardship ProgramsCurrent Infectious Disease ReportsGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018WHO Competency Framework for Health Workers’ Education and Training on Antimicrobial ResistanceWorld Health OrganizationGlobal4. Supporting education on AMR for the public and medical practitioners
2020AMR Clinical Reference CenterNational Center for Global Health and MedicineJapan4. Supporting education on AMR for the public and medical practitioners
2020e-BugUK Health Protection Agency (HPA)United Kingdom4. Supporting education on AMR for the public and medical practitioners
2020AMR Clinical Reference Center Educational Resources, AMR LearningNational Center for Global Health and MedicineJapan4. Supporting education on AMR for the public and medical practitioners
2015Securing New Drugs for Future Generations: The Pipeline of AntibioticsWellcome TrustGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2013Japan and Partners Team Up to Tackle Neglected DiseasesScientific AmericanJapan5. Establishing incentive models to encourage R&D for antimicrobials
2018Sustainable Access to Antimicrobials; A Missing Component to Antimicrobial Stewardship—A Tale of Two CountriesFrontiers in Public HealthGlobal 6. Stabilizing the supply of antimicrobials
2016Tackling Drug-Resistant Infections Globally: Final Report and RecommendationsWellcome TrustGlobal6. Stabilizing the supply of antimicrobials
2020Global Research Collaboration for Infectious Disease PreparednessMérieux FoundationJapan7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020GenEpid-J:Database of Pathogen Genomics and EpidemiologyNational Institute of Infectious DiseasesJapan7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2014Enhancing US-Japan Cooperation to Combat Antimicrobial ResistanceBiosecurity and Bioterrorism : Biodefense Strategy, Practice, and ScienceJapan7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015Global action plan on antimicrobial resistanceWorld Health OrganizationGlobal1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
4. Supporting education on AMR for the public and medical practitioners
7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020Global AMR R&D HubGlobal AMR R&D HubGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2018 Access to Medicine Index 2018Access to Medicine FoundationGlobal
6. Stabilizing the supply of antimicrobials
2017What is antimicrobial stewardship?Dyar, O. J., B. Huttner, J. Schouten, and C. Pulcini.Global1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2019Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkitWorld Health OrganizationLow-middle income countries1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2016Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009–2013)Muraki, Yuichi, Tetsuya Yagi, Yasuhiro Tsuji, Nobuhiro Nishimura, Masaki Tanabe, Takashi Niwa, Tamayo Watanabe et al. Japan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016Tsutsui, Atsuko, Koji Yahara, and Keigo ShibayamaJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012–2015 Hashimoto, Hideki, Makoto Saito, Jumpei Sato, Kazuo Goda, Naohiro Mitsutake, Masaru Kitsuregawa, Ryozo Nagai, and Shuji HatakeyamaJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018vol.9 The current state of drug resistance as seen in data. 2018-Let's know AMR, let's think about your medicine-AMR Clinical Reference CenterJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2017Manual of Antimicrobial Stewardship (1st Edition)Ministry of Health, Labour, and WelfareJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020A nationwide questionnaire survey of clinic doctors on antimicrobial stewardship in JapanGu, Yoshiaki, Yumiko Fujitomo, Hiroshi Soeda, Chikara Nakahama, Naoki Hasegawa, Shigefumi Maesaki, Masayuki Maeda, Tetsuya Matsumoto, Isao Miyairi, and Norio OhmagariJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
4. Supporting education on AMR for the public and medical practitioners
2019Manual of Antimicrobial Stewardship (2nd Edition)Ministry of Health, Labour, and WelfareJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018Additional reimbursement for antimicrobial stewardship – 100 pointsMinistry of Health, Labour, and WelfareJapan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2019The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of ChemotherapyMaeda, Masayuki, Yuichi Muraki, Tadashi Kosaka, Takehiro Yamada, Yosuke Aoki, Mitsuo Kaku, Tatsuya Kawaguchi et al.Japan1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018Global increase and geographic convergence in antibiotic consumption between 2000 and 2015Klein, Eili Y., Thomas P. Van Boeckel, Elena M. Martinez, Suraj Pant, Sumanth Gandra, Simon A. Levin, Herman Goossens, and Ramanan LaxminarayanGlobal1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018WHO Report on Surveillance of Antibiotic ConsumptionWorld Health OrganizationGlobal1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2015Global trends in antimicrobial use in food animalsVan Boeckel, Thomas P., Charles Brower, Marius Gilbert, Bryan T. Grenfell, Simon A. Levin, Timothy P. Robinson, Aude Teillant, and Ramanan LaxminarayanGlobal1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2008Antimicrobial drug use and resistance in EuropeVan De Sande-Bruinsma, Nienke, Hajo Grundmann, Didier Verloo, Edine Tiemersma, Jos Monen, Herman Goossens, Matus Ferech, and European Antimicrobial Resistance Surveillance SystemEurope1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2017Global Framework for Development & Stewardship to Combat Antimicrobial ResistanceWorld Health OrganizationGlobal1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2019Antibiotic Use in the United States, 2018 Update: Progress and OpportunitiesCenter for Disease Control and PreventionUnited States1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020TARGET Antibiotics ToolkitRoyal College of General PractitionersUnited Kingdom1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2020The South African Antibiotic Stewardship Progrmme (SAASP)Federation of Infectious Diseases Societies of Southern AfricaSouth Africa1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2013The Viet Nam Resistance Project Tackles Looming Antibiotic CrisisAsian ScientistVietnam1. Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
2018SurveillanceJapan International Cooperation AgencyJapan2. Constructing domestic AMR surveillance and crisis management systems
2018Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratoriesTsutsui, Atsuko, and Satowa SuzukiJapan2. Constructing domestic AMR surveillance and crisis management systems
2018AMR Indicators and their relevance to the global indicator framework for the SDGs and targets for the 2030 Agenda for Sustainable DevelopmentWorld Health OrganizationGlobal2. Constructing domestic AMR surveillance and crisis management systems
2013Infectious Disease Control LawMinistry of Health, Labour, and WelfareJapan2. Constructing domestic AMR surveillance and crisis management systems
2020JANIS: List of participating institutionsMinistry of Health, Labour, and WelfareJapan2. Constructing domestic AMR surveillance and crisis management systems
2019Budget request for fiscal year 2020Ministry of Health, Labour, and WelfareJapan2. Constructing domestic AMR surveillance and crisis management systems
2019Guidance for responding to antimicrobial resistant bacteria in small and medium sized hospitalsAMR Clinical Reference CenterJapan2. Constructing domestic AMR surveillance and crisis management systems
2019Access to nationwide antimicrobial resistance (AMR) countermeasures by medical facilities: release of J-SIPHE platformAMR Clinical Reference CenterJapan2. Constructing domestic AMR surveillance and crisis management systems
2019Global antimicrobial resistance surveillance system (GLASS) report 2017-2018World Health OrganizationGlobal2. Constructing domestic AMR surveillance and crisis management systems
7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019GLASS Enrolled countries – Feb 2020World Health OrganizationGlobal2. Constructing domestic AMR surveillance and crisis management systems
2014The bigger picture: the history of antibiotics and antimicrobial resistance displayed by scientometric data Brandt, Christian, Oliwia Makarewicz, Thomas Fischer, Claudia Stein, Yvonne Pfeifer, Guido Werner, and Mathias W. PletzGlobal2. Constructing domestic AMR surveillance and crisis management systems
2016Antimicrobial resistance: A manual for developing national action plansWorld Health Organization, Food and Agriculture Organization of the United Nations, World Organization for Animal HealthGlobal2. Constructing domestic AMR surveillance and crisis management systems
2019Library of national action plansWorld Health OrganizationGlobal2. Constructing domestic AMR surveillance and crisis management systems
2015U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria (National Action Plan)Center for Disease Control and PreventionUnited States2. Constructing domestic AMR surveillance and crisis management systems
2018Global Infection Prevention and Control Network Meeting ReportWorld Health OrganizationGlobal2. Constructing domestic AMR surveillance and crisis management systems
2018G20 experts stage a fake superbug pandemic to test how the world would react to a deadly outbreak of an antibiotic-resistant diseaseBlanchard, SamGlobal2. Constructing domestic AMR surveillance and crisis management systems
2016Declaration by Pharmaceutical, Biotechnology and Diagnostic Industries on Combating Antimicrobial ResistanceAMR Industry AllianceGlobal2. Constructing domestic AMR surveillance and crisis management systems
7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016Infection prevention, control and surveillance: Limiting the development and spread of drug resistance - review on antimicrobial resistanceO’Neill, JimGlobal2. Constructing domestic AMR surveillance and crisis management systems
2019Antibiotic prescribing without documented indication in ambulatory care clinics: national cross sectional studyRay, Michael J., Gregory B. Tallman, David T. Bearden, Miriam R. Elman, and Jessina C. McGregorUnited States3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017The White Paper on rapid diagnostic technologies to tackle AMRHealth First EuropeGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016Microbiological testing method useful for measures against AMR ~Screening and Identification of AMR~Nakamura, TatsuyaJapan3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018Innovation in AMR: patent trends for novel diagnostics longitude prizeLongitude PrizeGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019G20 Osaka leaders’ declarationG20Global3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019Okayama Declaration of the G20 Health MinistersG20Global3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
6. Stabilizing the supply of antimicrobials
2017Emerging and re-emerging infectious disease control projectJapan Agency for Medical Research and Development (AMED)Japan3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019FY2019 (Reiwa 1) Institutions / Topic List- Research Project for Practical Research of Infectious Diseases (Project for Promoting Development of Innovative Drugs for Emerging and Re-emerging Infectious Diseases)Japan Agency for Medical Research and Development (AMED)Japan3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2017Microbial testing/rapid testing/cytology testingBecton Dickinson and Company JapanGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018Potential for reducing inappropriate antibiotic prescribing in English primary careSmieszek, Timo, Koen B. Pouwels, F. Christiaan K. Dolk, David RM Smith, Susan Hopkins, Mike Sharland, Alastair D. Hay, Michael V. Moore, and Julie V. RobothamUnited Kingdom3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2018The $28+ Billion Worldwide Market for Rapid Diagnostic Kits (2018-2023)GlobalNewsWireGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex ‘mix-and-match’ implementation package.Hays, John P., Konstantinos Mitsakakis, Saturnino Luz, Alex van Belkum, Karsten Becker, Ann van den Bruel, Stephan Harbarth et al.Global3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2020Longitude PrizeLongitude PrizeGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2016Ensuring innovation in diagnostics for bacterial infection: Implications for policyWorld Health OrganizationGlobal3. Enabling the further and active use of AMR screening methods and rapid diagnostic technology
2019How to improve antibiotic awareness campaigns: findings of a WHO global surveyHuttner, Benedikt, Mirko Saam, Lorenzo Moja, Karen Mah, Marc Sprenger, Stephan Harbarth, and Nicola MagriniGlobal4. Supporting education on AMR for the public and medical practitioners
2010The English antibiotic awareness campaigns: did they change the public's knowledge of and attitudes to antibiotic use?McNulty, Cliodna AM, Tom Nichols, Paul J. Boyle, Mark Woodhead, and Peter DaveyUnited Kingdom4. Supporting education on AMR for the public and medical practitioners
20192019 Survey on Healthcare in JapanHealth and Global Policy InstituteJapan4. Supporting education on AMR for the public and medical practitioners
2018More than 80% of Americans are concerned about health threat posed by antibiotic resistanceResearch!AmericaUnited States4. Supporting education on AMR for the public and medical practitioners
2017Public Awareness Raising Activities on AMRHasegawa, ManabuJapan4. Supporting education on AMR for the public and medical practitioners
2019Public Awareness and Educational Activities to Improve Knowledge and Understanding of Antimicrobial Resistance (AMR) in JapanAkie Araim, Yoshinori Takahashi, Akiko Nakamura, Masaki TanabeJapan4. Supporting education on AMR for the public and medical practitioners
2015Antibiotic resistance: Multi-country public awareness survey”World Health OrganizationGlobal4. Supporting education on AMR for the public and medical practitioners
2013Public knowledge, attitudes, and experience regarding the use of antibiotics in ItalyNapolitano, Francesco, Maria Teresa Izzo, Gabriella Di Giuseppe, and Italo F. AngelilloItaly4. Supporting education on AMR for the public and medical practitioners
2019Public understanding and use of antibiotics in England: findings from a household survey in 2017McNulty, Cliodna AM, Simon M. Collin, Emily Cooper, Donna M. Lecky, and Chris C. ButlerEngland4. Supporting education on AMR for the public and medical practitioners
2010A survey of public knowledge and awareness related to antibiotic use and resistance in SwedenAndré, Malin, Åsa Vernby, Johanna Berg, and Cecilia Stålsby LundborgSweden4. Supporting education on AMR for the public and medical practitioners
2013Medical students’ perceptions and knowledge about antimicrobial stewardship: how are we educating our future prescribers?Abbo, Lilian M., Sara E. Cosgrove, Paul S. Pottinger, Margaret Pereyra, Ronda Sinkowitz-Cochran, Arjun Srinivasan, David J. Webb, and Thomas M. HootonEngland4. Supporting education on AMR for the public and medical practitioners
2017Canadian physicians’ knowledge and counseling practices related to antibiotic use and antimicrobial resistance: Two-cycle national surveySmith, Courtney R., Lisa Pogany, Simon Foley, Jun Wu, Karen Timmerman, Margaret Gale-Rowe, and Alain DemersCanada4. Supporting education on AMR for the public and medical practitioners
2019Knowledge and Attitude of General Pakistani Population Towards Antibiotic ResistanceAkhund, Ramsha, Fatima Jamshed, Hassam A. Jaffry, Hamza Hanif, and Sundus FareedPakistan4. Supporting education on AMR for the public and medical practitioners
2018The consequences of AMR education and awareness raising: outputs, outcomes, and behavioural impacts of an antibiotic-related educational activity in Lao PDR.Haenssgen, Marco J., Thipphaphone Xayavong, Nutcha Charoenboon, Penporn Warapikuptanun, and Yuzana Khine ZawLaos4. Supporting education on AMR for the public and medical practitioners
2019World Antibiotic Awareness WeekWorld Health OrganizationGlobal4. Supporting education on AMR for the public and medical practitioners
2011Overview of e-Bug: an antibiotic and hygiene educational resource for schoolsMcNulty, Cliodna AM, Donna M. Lecky, David Farrell, Patty Kostkova, Niels Adriaenssens, Tereza Koprivová Herotová, Jette Holt et alEurope4. Supporting education on AMR for the public and medical practitioners
2012Antibiotic prescribing in primary care, adherence to guidelines and unnecessary prescribing-an Irish perspectiveMurphy, Marion, Colin P. Bradley, and Stephen ByrneIreland4. Supporting education on AMR for the public and medical practitioners
2020ReACT - About usReACTGlobal4. Supporting education on AMR for the public and medical practitioners
7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2020Read Antimicrobial Resistance Fighter StoriesAntimicrobial Resistance Fighter CoalitionGlobal4. Supporting education on AMR for the public and medical practitioners
2019Superheroes Against Superbugs Pilot ReportWellcomeTrust/DBT Indian Alliance, World Comics India, Centre for Cellular and Molecular BiologyIndia4. Supporting education on AMR for the public and medical practitioners
2011Challenges of antibacterial discoverySilver, Lynn LGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2019(Inter) nationalising the antibiotic research and development pipelineSinger, Andrew C., Claas Kirchhelle, and Adam P. RobertsGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2018Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050Hu, CharlotteGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2019Achaogen bankruptcy highlights antibacterial development woesMullard, AsherGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2018The need for AMR pull incentivesInternational Federation of Pharmaceutical Manufactures & AssociationsGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2017Antimicrobial Reistance (AMR) Symposium: AMED The Forefront of R&D from basics to drug discovery - AMR Research, Current State of the WorldTateda, KazuhiroJapan5. Establishing incentive models to encourage R&D for antimicrobials
2019Although the market is expanding 1.9 times, it is the beginning of the negative growth era – reflecting on the pharmaceufcal market data during the Heisei eraMaeda, YukiJapan5. Establishing incentive models to encourage R&D for antimicrobials
2017[Fuji Economic Survey] Infectious Diseases Market, 30% decrease to 555.2 billion yen in 2024Yakuji Nippo, Ltd.Japan5. Establishing incentive models to encourage R&D for antimicrobials
2013Strategy and direction to overcome stagnation of antimicrobial developmentTateda, KazuhiroJapan5. Establishing incentive models to encourage R&D for antimicrobials
2018CiCLE: Cyclic Innovation for Clinical EmpowermentJapan Agency for Medical Research and Development (AMED)Japan5. Establishing incentive models to encourage R&D for antimicrobials
2019Research Project to Promote the Development of Innovative Drugs for Emerging and Re-Emerging Infectious DiseasesJapan Agency for Medical Research and Development (AMED)Japan5. Establishing incentive models to encourage R&D for antimicrobials
2017Scheme to expedite unapproved drugs for antimicrobial resistant diseases to incentivize developmentMinistry of Health, Labour, and WelfareJapan5. Establishing incentive models to encourage R&D for antimicrobials
2018GARDP, Eisai and Takeda announce partnership in the search for new antibioticsTakeda Pharmaceuticals Co., Ltd.Japan5. Establishing incentive models to encourage R&D for antimicrobials
2019Japan Archives – AMR Industry AllianceAMR Industry AllianceJapan5. Establishing incentive models to encourage R&D for antimicrobials
2019FY2019 (Reiwa 1) Institutions / Topic List- Research Project for Practical Research of Infectious DiseasesJapan Agency for Medical Research and Development (AMED)Japan5. Establishing incentive models to encourage R&D for antimicrobials
2017Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigationTowse, Adrian, Christopher K. Hoyle, Jonathan Goodall, Mark Hirsch, Jorge Mestre-Ferrandiz, and John H. RexGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2019Antibiotics Aren’t Profitable Enough for Big Pharma to Make MoreLangreth, RobertGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2018Global Health Observatory on Health R&D: Antibacterial products in clinical development for priority pathogensWorld Health OrganizationGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2018Medicines in Development for Cancer 2018 ReportPharmaceutical Research and Manufactures of AmericaGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2019The global preclinical antibacterial pipelineTheuretzbacher, Ursula, Kevin Outterson, Aleks Engel, and Anders KarlénGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2020Research and DevelopmentGlobal Antibiotic Research and Development PartnershipGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2018GARDP: a not-for-profit research and development organization to address antimicrobial resistanceDrugs for Neglected Diseases initiativeGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2020Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator - OverviewCombating Antibiotic Resistant Bacteria Biopharmaceutical AcceleratorGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2016Economic incentives for antibacterial drug development: literature review and considerations from the Transatlantic Task Force on Antimicrobial ResistanceSciarretta, Kimberly, John-Arne Røttingen, Aleksandra Opalska, Arjon J. Van Hengel, and Joseph LarsenGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2020ND4BB: New Drugs for Bad BugsInnovative Medicines InitiativeGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2018Boosting the fight against drug­ resistant bacteria in hospitalsInnovative Medicines InitiativeGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2020ENABLE: European Gram­Negative Antibacterial EngineInnovative Medicines InitiativeGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2017Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.Chan, Pan F., Thomas Germe, Benjamin D. Bax, Jianzhong Huang, Reema K. Thalji, Eric Bacqué, Anna Checchia et al. Global5. Establishing incentive models to encourage R&D for antimicrobials
2019Joint Programming Initiative on Antimicrobial Resistance - Supported projects.Joint Programming Initiative on Antimicrobial Resistance Global5. Establishing incentive models to encourage R&D for antimicrobials
2020REPAIR Impact Fund - AboutNovo Nordsik FoundationGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2019Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action planUnited Kingdom GovernmentUnited Kingdom5. Establishing incentive models to encourage R&D for antimicrobials
2018Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to comeAMR Industry AllianceGlobal5. Establishing incentive models to encourage R&D for antimicrobials
2017International StrategyMedicines and Healthcare Products Regulatory AgencyGlobal6. Stabilizing the supply of antimicrobials
2013Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialistsGundlapalli, Adi V., Susan E. Beekmann, Donald R. Graham, Philip M. Polgreen, and Infectious Diseases Society of America's Emerging Infections NetworkUnited States6. Stabilizing the supply of antimicrobials
2020Critical national shortage of cefazolin in Japan: management strategiesHonda, Hitoshi, Shutaro Murakami, Yasuharu Tokuda, Yasuaki Tagashira, and Akane TakamatsuJapan6. Stabilizing the supply of antimicrobials
2019Suspension of cefazolin, surgeries affected, hospitals in panicAsahi ShimbunJapan6. Stabilizing the supply of antimicrobials
2019Recommendations by four academic societies for the stable supply of antimicrobialsJapan Society for Infection Prevention and Control, Japan Society of Chemotherapy, the Japan Association of Infectious Diseases, and Japan Society of Clinical Microbiology Japan6. Stabilizing the supply of antimicrobials
2019IQVIA Heisei era’s drug market: Antibacterial drugs in the first half, lifestyle-related drugs in the second half, antitumor drugs in the second half dominateMixJapan6. Stabilizing the supply of antimicrobials
2019Nichi-Iko invests 1.5 billion yen in stable supply of cefazolinNikkei MedicalJapan6. Stabilizing the supply of antimicrobials
2015Antibacterial drug shortages from 2001 to 2013: implications for clinical practice.Quadri, Farha, Maryann Mazer-Amirshahi, Erin R. Fox, Kristy L. Hawley, Jesse M. Pines, Mark S. Zocchi, and Larissa MayGlobal6. Stabilizing the supply of antimicrobials
2018Shortages, stockouts and scarcityCogan, Deirdre, Karrar Karrar, and Jayasree K. IyerGlobal6. Stabilizing the supply of antimicrobials
2019Meeting report: antibiotic shortages: magnitude, causes and possible solutionsWorld Health OrganizationGlobal6. Stabilizing the supply of antimicrobials
2019Drug Shortages: Root Causes and Potential SolutionFood and Drug AdministrationUnited States6. Stabilizing the supply of antimicrobials
2011Prescription drug shortages: examining a public health concern and potential solutions.United States Committee on Health, Education, Labor, and PensionsGlobal6. Stabilizing the supply of antimicrobials
2018Fragile Antibiotic Supply Chain Causes Shortages And Is A National Security ThreatStone, JudyGlobal6. Stabilizing the supply of antimicrobials
2019Access Barriers to AntibioticsCenter for Disease Dynamics, Economics & PolicyGlobal6. Stabilizing the supply of antimicrobials
2014Drive-AB - AboutDrive-ABGlobal6. Stabilizing the supply of antimicrobials
2019Shionogi announces out-licensing agreement with AMR Centre on COT-143, a humanized monoclonal antibody targeting the PcrV protein of Pseudomonas aeruginosaShionogi & Co., Ltd.Global6. Stabilizing the supply of antimicrobials
2014Annual report of the network for monitoring/surveillance of antibiotic resistance and health care associated infections – 2014Pan American Health OrganizationAmericas2. Constructing domestic AMR surveillance and crisis management systems
2017One HealthWorld Health OrganizationGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015The article by Prime Minister Shinzo Abe on the Lancet. Japan's vision for a peaceful and healthier worldMinistry of Foreign AffairsJapan7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015Japan’s vision for a peaceful and healthier worldMinistry of Foreign AffairsJapan7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2015Global trends in antimicrobial use in food animalsVan Boeckel, Thomas P., Charles Brower, Marius Gilbert, Bryan T. Grenfell, Simon A. Levin, Timothy P. Robinson, Aude Teillant, and Ramanan LaxminarayanGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019Antimicrobial Resistance in the Asia Pacific region: a meeting reportYam, Esabelle Lo Yan, Li Yang Hsu, Eric Peng-Huat Yap, Tsin Wen Yeo, Vernon Lee, Joergen Schlundt, May O. Lwin et alAsia-Pacific7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019Chair Summary Tokyo AMR One Health ConferenceMinistry of Health, Labour, and WelfareJapan7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2019The 6th Nikkei Asia Africa Conference on Communicable Diseases 2019 – Big Step towards Borderless Initiative through Public-Private PartnershipThe Nihon Keizai ShimbunAsia/Africa7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016UN Interagency Coordination Group (IACG) on Antimicrobial ResistanceWorld Health OrganizationGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2018A new alliance joins the fight against antimicrobial resistanceBurki, Talha KhanGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016The FAO action plan on antimicrobial resistance 2016–2020Food and Agriculture Organization of the United Nations (FAO)Global7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016The OIE strategy on antimicrobial resistance and the prudent use of antimicrobialsWorld Organization for Animal HealthGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2016Draft political declaration of the high-level meeting of the General Assembly on antimicrobial resistanceUnited NationsGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2018Transatlantic Taskforce on Antimicrobial Resistance (TATFAR)Center for Disease Control and PreventionGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad
2017AMR Industry Alliance - Why the AMR Industry Alliance?AMR Industry AllianceGlobal7. International collaborations to share case studies and lessons learned on AMR domestically and abroad

gotoTop